Cell-free assays reveal the HIV-1 capsid protects reverse transcripts from cGAS.
Tiana M ScottLydia M ArnoldJordan A PowersDelaney A McCannDevin E ChristensenMiguel J PereiraWen ZhouRachel M TorrezJanet H IwasaPhilip J KranzuschWesley I SundquistJarrod S JohnsonPublished in: bioRxiv : the preprint server for biology (2024)
Retroviruses can be detected by the innate immune sensor cyclic GMP-AMP synthase (cGAS), which recognizes reverse-transcribed DNA and activates an antiviral response. However, the extent to which HIV-1 shields its genome from cGAS recognition remains unclear. To study this process in mechanistic detail, we reconstituted reverse transcription, genome release, and innate immune sensing of HIV-1 in a cell-free system. We found that wild-type HIV-1 capsids protect their genomes from cGAS even after completion of reverse transcription. Viral DNA could be "deprotected" by thermal stress, capsid mutations, or reduced concentrations of inositol hexakisphosphate (IP6) that destabilize the capsid. Strikingly, capsid inhibitors also disrupted viral cores and dramatically potentiated cGAS activity, both in vitro and in cellular infections. Our results provide biochemical evidence that the HIV-1 capsid lattice conceals the genome from cGAS and that chemical or physical disruption of the viral core can expose HIV-1 DNA and activate innate immune signaling.
Keyphrases
- cell free
- antiretroviral therapy
- hiv positive
- innate immune
- hiv testing
- hiv infected
- human immunodeficiency virus
- hepatitis c virus
- circulating tumor
- hiv aids
- men who have sex with men
- sars cov
- genome wide
- south africa
- transcription factor
- physical activity
- dna methylation
- single cell
- staphylococcus aureus
- high throughput